5,5-Dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane

Catalog No. :
ACQZDT460
CAS No. :
1416371-19-1
Molecular Formula :
C19H19BO2
Molecular Weight :
290.17

IUPAC Name:5,5-dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane

5,5-Dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$111.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,5-Dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane
IUPAC Name5,5-dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane
MDL No.MFCD32876919
Molecular FormulaC19H19BO2
Molecular Weight290.17
SMILESCC1(C)COB(C2=CC3=CC=CC=C3C4=CC=CC=C42)OC1
InChI KeyWZXSJDKNWAQBOL-UHFFFAOYSA-N
Synonym9-Phenanthreneboronic acid neopentylglycol ester;5,5-Dimethyl-2-(phenanthren-9-yl)-1,3,2-dioxaborinane;3-Hydroxy-2,2-dimethyl Propyl Hydrogen 9-phenanthryl Boronate;1,3,2-Dioxaborinane, 5,5-dimethyl-2-(9-phenanthrenyl)-;3-Hydroxy-2,2-dimethylpropyl hydrogen phenanthren-9-ylboronate
CAS No.1416371-19-1
PubChem CID101882769

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQZDT460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLKZO273 route compound structure diagram
    ACLKZO273573-17-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZDT460 route product structure diagram
    ACQZDT4601416371-19-1 In Stock
Inquiry

2. ACQZDT460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLKZO273 route compound structure diagram
    ACLKZO273573-17-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZDT460 route product structure diagram
    ACQZDT4601416371-19-1 In Stock
Inquiry

Comments (0)